Sildenafil Citrate Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 25 mg, 50 mg, 100 mg; For pulmonary: 20 mg, 40 mg, 60 mg, 80 mg
Reference Brands: (US & EU): Viagra, Revatio (for pulmonary hypertension)
Category:
Sexual Wellness
Sildenafil citrate inhibits phosphodiesterase type 5 (PDE5), enhancing nitric oxide effects and increasing blood flow to the penis. It effectively treats erectile dysfunction, improving sexual function and confidence. Benefits include rapid onset, ease of use, and improved quality of life for men with ED, supporting healthier intimate relationships
Sildenafil Citrate tablets is available in Tablet
and strengths such as 25 mg, 50 mg, 100 mg; For pulmonary: 20 mg, 40 mg, 60 mg, 80 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Sildenafil Citrate tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Sildenafil Citrate tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Sildenafil citrate tablets, marketed as Viagra and Revatio, are approved in the US by the FDA and in the EU via EMA for erectile dysfunction and pulmonary hypertension, respectively. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, FDA review involves detailed clinical and quality assessments, while the EMA ensures compliance with regional safety and manufacturing regulations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing